TGFB1 and cancer: Beyond PD-L1 and TGF-β, cancer-derived EVs may act as immune system suppressors based on the mechanism of NKG2D downregulation and subsequent natural killer cell cytotoxicity suppression described above (Szczepanski et al., 2011).